Chlorpheniramine Maleate; Codeine Phosphate Patent Expiration

Chlorpheniramine Maleate; Codeine Phosphate is Used for treating cough and symptoms of upper respiratory allergies or the common cold. It was first introduced by Mainpointe Pharmaceuticals Llc in its drug Tuxarin Er on Jun 22, 2015.


Chlorpheniramine Maleate; Codeine Phosphate Patents

Given below is the list of patents protecting Chlorpheniramine Maleate; Codeine Phosphate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Tuxarin Er US9066942 Oral dosage forms for oxygen-containing active agents and oxyl-containing polymer Jan 03, 2032 Mainpointe
Tuxarin Er US9107921 Oral dosage forms for oxygen containing active agents and oxyl-containing polymers Jan 03, 2032 Mainpointe
Tuxarin Er US6248363 Solid carriers for improved delivery of active ingredients in pharmaceutical compositions Nov 23, 2019

(Expired)

Mainpointe
Tuxarin Er US6383471 Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents Apr 06, 2019

(Expired)

Mainpointe



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Chlorpheniramine Maleate; Codeine Phosphate's patents.

Given below is the list recent legal activities going on the following patents of Chlorpheniramine Maleate; Codeine Phosphate.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 8th Yr, Small Entity 08 Feb, 2023 US9107921
Payment of Maintenance Fee, 8th Yr, Small Entity 01 Dec, 2022 US9066942
Surcharge for late Payment, Small Entity 02 Jan, 2019 US9066942
Payment of Maintenance Fee, 4th Yr, Small Entity 02 Jan, 2019 US9066942
Payment of Maintenance Fee, 4th Yr, Small Entity 30 Nov, 2018 US9107921
Application ready for PDX access by participating foreign offices 31 Aug, 2015 US9066942
Application ready for PDX access by participating foreign offices 31 Aug, 2015 US9107921
Patent Issue Date Used in PTA Calculation 18 Aug, 2015 US9107921
Recordation of Patent Grant Mailed 18 Aug, 2015 US9107921
Email Notification 30 Jul, 2015 US9107921


Chlorpheniramine Maleate; Codeine Phosphate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List